(Q44686337)

5 December 2017

Vascular localization of soluble epoxide hydrolase in the human kidney (English)

1 reference

Soluble epoxide hydrolase

5 December 2017

0 references

author name string

Zhigang Yu

1

1 reference

5 December 2017

Benjamin B Davis

2

1 reference

5 December 2017

Christophe Morisseau

3

1 reference

5 December 2017

Bruce D Hammock

4

1 reference

5 December 2017

Jean L Olson

5

1 reference

5 December 2017

Deanna L Kroetz

6

1 reference

5 December 2017

Robert H Weiss

7

1 reference

5 December 2017

language of work or name

1 reference

9 December 2003

1 reference

American Journal of Physiology - Renal Physiology

5 December 2017

1 reference

5 December 2017

286

1 reference

5 December 2017

4

1 reference

5 December 2017

F720-6

1 reference

Improved radiolabeled substrates for soluble epoxide hydrolase

5 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Novel renal arachidonate metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Distribution and properties of a mammalian soluble epoxide hydrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Genetic and environmental factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Effects of epoxyeicosatrienoic acids on polymorphonuclear leukocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Polymorphisms in human soluble epoxide hydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Effects of epoxyeicosatrienoic acids on 86Rb uptake in renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Cytosolic epoxide hydrolase in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00165.2003

10.1152/AJPRENAL.00165.2003

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference